Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Operating Income (QoQ) (2009 - 2026)

Analysis

Resmed (RMD) Operating Income (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.22%
Mar 31, 2026 1.66%
Dec 31, 2025 10.11%
Sep 30, 2025 -1.76%
Jun 30, 2025 6.63%
Mar 31, 2025 2.16%
Dec 31, 2024 7.73%
Sep 30, 2024 1.60%
Jun 30, 2024 1.77%
Mar 31, 2024 36.17%
Dec 31, 2023 -4.81%
Sep 30, 2023 4.99%
Jun 30, 2023 -8.45%
Mar 31, 2023 7.31%
Dec 31, 2022 1.62%
Sep 30, 2022 7.96%
Jun 30, 2022 9.02%
Mar 31, 2022 -5.81%
Dec 31, 2021 -5.04%
Sep 30, 2021 8.39%